1 |
中国心血管健康与疾病报告组. 中国心血管健康与疾病报告2022概要[J]. 中国循环杂志, 2023, 38(6): 583-612.
|
|
The Writing Committee of the Report on Cardiovascular Health and Disease in China. Report on cardiovascular health and diseases in China 2022: an updated summary[J]. Chinese Circulation Journal,2023, 38(6): 583-612.
|
2 |
BYRNE R A, ROSSELLO X, COUGHLAN J J, et al. 2023 ESC Guidelines for the management of acute coronary syndromes[J]. Eur Heart J, 2023, 44(38): 3720-3826.
|
3 |
AFILALO J, KARUNANANTHAN S, EISENBERG M J, et al. Role of frailty in patients with cardiovascular disease[J]. Am J Cardiol, 2009, 103(11): 1616-1621.
|
4 |
SHAMLIYAN T, TALLEY K M, RAMAKRISHNAN R, et al. Association of frailty with survival: a systematic literature review[J]. Ageing Res Rev, 2013, 12(2): 719-736.
|
5 |
VERONESE N, CEREDA E, STUBBS B, et al. Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: results from a meta-analysis and exploratory meta-regression analysis[J]. Ageing Res Rev, 2017, 35: 63-73.
|
6 |
CLEGG A, YOUNG J, ILIFFE S, et al. Frailty in elderly people[J]. Lancet, 2013, 381(9868): 752-762.
|
7 |
CHUNG K J N C, WILKINSON C, VEERASAMY M, et al. Frailty scores and their utility in older patients with cardiovascular disease[J]. Interv Cardiol, 2021, 16: e05.
|
8 |
WHITE H D, WESTERHOUT C M, OHMAN E M, et al. Frailty is associated with worse outcomes in non ST-segment elevation acute coronary syndromes: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial[J]. Eur Heart J Acute Cardiovasc Care, 2016, 5(3): 231-242.
|
9 |
SINCLAIR H, BATTY J A, QIU W, et al. Engaging older patients in cardiovascular research: observational analysis of the ICON-1 study[J]. Open Heart, 2016, 3(2): e000436.
|
10 |
ROSENGREN A, WALLENTIN L, SIMOONS M, et al. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey[J]. Eur Heart J, 2006, 27(7): 789-795.
|
11 |
LOPES R D, WHITE J A, TRICOCI P, et al. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial[J]. Int J Cardiol, 2013, 167(6): 2580-2587.
|
12 |
BESKA B, MILLS G B, KUNADIAN V, et al. Impact of multimorbidity on long-term outcomes in older adults with non-ST elevation acutecoronary syndrome in the North East of England: a multi-centre cohort study of patients undergoing invasive care[J]. BMJ Open, 2022, 12(7): e061830.
|
13 |
BESKA B, COAKLEY D, MACGOWAN G, et al. Frailty and quality of life after invasive management for non-ST elevation acute coronary syndrome[J]. Heart, 2022, 108(3): 203-211.
|
14 |
EKERSTAD N, JAVADZADEH D, ALEXANDER K P, et al. Clinical Frailty Scale classes are independently associated with 6-month mortality for patients after acute myocardial infarction[J]. Eur Heart J Acute Cardiovasc Care, 2022, 11(2): 89-98.
|
15 |
THEOU O, SQUIRES E, MALLERY K, et al. What do we know about frailty in the acute care setting? A scoping review[J]. BMC Geriatr, 2018, 18(1): 139.
|
16 |
ROCKWOOD K, THEOU O. Using the clinical frailty scale in allocating scarce health care resources[J]. Can Geriatr J, 2020, 23(3): 210-215.
|
17 |
EKERSTAD N, PETTERSSON S, ALEXANDER K, et al. Frailty as an instrument for evaluation of elderly patients with non-ST-segment elevation myocardial infarction: a follow-up after more than 5 years[J]. Eur J Prev Cardiol, 2018, 25(17): 1813-1821.
|
18 |
AMBROSETTI M, ABREU A, CORRÀ U, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: from knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology[J]. Eur J Prev Cardiol, 2021, 28(5): 460-495.
|
19 |
ABREU A, FREDERIX I, DENDALE P, et al. Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: the avenue towards EAPC accreditation programme: a position statement of the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology (EAPC)[J]. Eur J Prev Cardiol, 2021, 28(5): 496-509.
|
20 |
KEHLER D S, GIACOMANTONIO N, FIRTH W, et al. Association between cardiac rehabilitation and frailty[J]. Can J Cardiol, 2020, 36(4): 482-489.
|
21 |
QUACH J, KEHLER D S, GIACOMANTONIO N, et al. Association of admission frailty and frailty changes during cardiac rehabilitation with 5-year outcomes[J]. Eur J Prev Cardiol, 2023, 30(9): 807-819.
|
22 |
KEHLER D S, GIACOMANTONIO N, FIRTH W, et al. Association between cardiac rehabilitation and frailty[J]. Can J Cardiol, 2020, 36(4): 482-489.
|
23 |
LUTZ A H, DELLIGATTI A, ALLSUP K, et al. Cardiac rehabilitation is associated with improved physical function in frail older adults with cardiovascular disease[J]. J Cardiopulm Rehabil Prev, 2020, 40(5): 310-318.
|
24 |
RAUCH B, DAVOS C H, DOHERTY P, et al. The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: a systematic review and meta-analysis of randomized and non-randomized studies: the Cardiac Rehabilitation Outcome Study (CROS)[J]. Eur J Prev Cardiol, 2016, 23(18): 1914-1939.
|
25 |
REA F, RONCO R, PEDRETTI R F E, et al. Better adherence with out-of-hospital healthcare improved long-term prognosis of acute coronary syndromes: evidence from an Italian real-world investigation[J]. Int J Cardiol, 2020, 318: 14-20.
|
26 |
SALZWEDEL A, JENSEN K, RAUCH B, et al. Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: update of the Cardiac Rehabilitation Outcome Study (CROS-II)[J]. Eur J Prev Cardiol, 2020, 27(16): 1756-1774.
|
27 |
俞莞琦, 洪雯, 潘静薇, 等. 急性心肌梗死患者早期康复实践及影响因素分析[J]. 海军军医大学学报, 2022, 43(10): 1143-1148.
|
|
YU W Q, HONG W, PAN J W, et al. Early mobilization and its influencing factors in patients with acute myocardial infraction[J]. Academic Journal of Naval Medical University, 2022, 43(10): 1143-1148.
|
28 |
THYGESEN K, ALPERT J S, JAFFE A S, et al. Fourth universal definition of myocardial infarction (2018)[J]. Eur Heart J, 2019, 40(3): 237-269.
|
29 |
袁丽霞, 丁荣晶. 中国心脏康复与二级预防指南解读[J]. 中国循环杂志, 2019, 34(S01): 86-90.
|
|
YUAN L X, DING R J. Interpretation of guidelines for cardiac rehabilitation and secondary prevention in China[J]. Chinese Circulation Journal, 2019, 34(S01):86-90.
|
30 |
YNDIGEGN T, GILJE P, DANKIEWICZ J, et al. Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study[J]. EuroIntervention, 2022, 17(13): 1091-1099.
|
31 |
SETO A H, SHROFF A, ABU-FADEL M, et al. Length of stay following percutaneous coronary intervention: an expert consensus document update from the society for cardiovascular angiography and interventions[J]. Catheter Cardiovasc Interv, 2018, 92(4): 717-731.
|
32 |
LI N, CHEN R Z, LI J N, et al. Prognostic significance of serial N-terminal pro-B-type natriuretic peptide levels in patients with acute myocardial infarction: a prospective study [J]. Am Heart J, 2023, 262: 90-99.
|
33 |
MCKECHNIE D G J, PAPACOSTA A O, LENNON L T, et al. Associations between inflammation, cardiovascular biomarkers and incident frailty: the British Regional Heart Study[J]. Age Ageing, 2021, 50(6): 1979-1987.
|